Cargando…
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Nitazenes are a group of compounds developed in the 1950s as opioid analgesics, but they were never approved to market. As such, they are not well known outside of academic research laboratories. A characteristic of nitazenes is their high potency (e.g., hundreds to thousands fold more potent than m...
Autores principales: | Pergolizzi Jr, Joseph, Raffa, Robert, LeQuang, Jo Ann K, Breve, Frank, Varrassi, Giustino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361140/ https://www.ncbi.nlm.nih.gov/pubmed/37485167 http://dx.doi.org/10.7759/cureus.40736 |
Ejemplares similares
-
The New Stealth Drug on the Street: A Narrative Review of Xylazine as a Street Drug
por: Pergolizzi Jr, Joseph, et al.
Publicado: (2023) -
From Antidepressant Tianeptine to Street Drug ZaZa: A Narrative Review
por: Wagner, Morgan L, et al.
Publicado: (2023) -
Brave New Healthcare: A Narrative Review of Digital Healthcare in American Medicine
por: Pergolizzi Jr., Joseph, et al.
Publicado: (2023) -
What Do We Need to Know About Rising Rates of Idiopathic Pulmonary Fibrosis? A Narrative Review and Update
por: Pergolizzi, Joseph V., et al.
Publicado: (2023) -
Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review
por: Pergolizzi, Joseph, et al.
Publicado: (2023)